A University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining the extent of prostate cancer than the current standard MRI for intermediate and high-risk cases.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection retrieved 2 July 2024 from https://medicalxpress.com/news/2024-07-clinical-trial-gold-standard-prostate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Comparative analysis shows FAPI PET/CT improves staging of newly diagnosed breast cancerA comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer shows that FAPI PET/CT is more accurate in staging patients. Nearly 20 percent of patients were restaged by FAPI PET/CT, indicating the radiotracer's efficacies and benefits for clinical practice.
Weiterlesen »
AI-powered lesion delineation in prostate cancer PET/CT imagingA new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, 'Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer.'
Weiterlesen »
Revolutionary AI tool detects multiple cancers in whole-body PET/CT scansA novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
Weiterlesen »
Study says FAPI PET/CT bests FDG in predicting progressive lung diseaseIn a head-to-head study, FAPI PET/CT was found to be more predictive of progressive pulmonary fibrosis in interstitial lung disease (ILD) patients than 18F-FDG PET/CT.
Weiterlesen »
New AI tool accurately detects six different cancer types on whole-body PET/CT scansA novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
Weiterlesen »
PET/CT provides superior lesion detection for head and neck paragangliomas compared to gold standard MRIA novel imaging approach—68Ga-DOTATATE PET/CT—can more accurately differentiate residual/recurrent tumors from post-surgery scar tissue in patients with head and neck paragangliomas (HNPGLs) compared to MRI.
Weiterlesen »